Mar 13, 2019 / 12:00PM GMT
Irina Margine - Cowen and Company, LLC, Research Division - Research Associate
Good morning, everyone, and welcome to Cowen's 2019 Health Care Conference. My name is Irina Margine. I'm on the Biotech Equity Research Team.
And it is my pleasure to introduce this morning, John Thero, CEO of Amarin.
John F. Thero - Amarin Corporation plc - President, CEO & Director
Thank you for that introduction. And thanks, everybody, for joining me here this morning. We've made a lot of progress since Cowen's last Health Care Conference, and I think we'll make a lot of progress between now and next Cowen's Health Care Conference. And since I've already jumped into forward-looking statements, I will disclaim that there are risks involved with all such statements, anybody considering investing should review our risk factors as filed in our SEC statements.
So Amarin is in the cardiovascular space and, cardiovascular disease, as hopefully you know, is an enormous and worsening public health burden. We see an urgent need and that, the current solutions out
Amarin Corporation PLC at Cowen Health Care Conference Transcript
Mar 13, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers